Guizhou Bailing Group Pharmaceutical Co.,Ltd. Fundamental Rankings
This page is comprehensive fundamental data for Guizhou Bailing Group Pharmaceutical Co.,Ltd.. Fundamentals are ordered by how Guizhou Bailing Group Pharmaceutical Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.
Cite in Wikipedia:
| Indicator | Value | n/price | Rank | Date | Historic |
|---|---|---|---|---|---|
| Productive biological assets | 26,442,510 | 0.00103 | 37 | 2015-06-30 | historic |
| Interest receivable | 13,105,264 | 5.1E-4 | 159 | 2015-06-30 | historic |
| Other current liabilities | 1,869,826 | 7.0E-5 | 342 | 2015-06-30 | historic |
| Net cash flows from investing activities | -57,874,516 | -0.00226 | 377 | 2015-06-30 | historic |
| Notes receivable | 301,188,322 | 0.01174 | 391 | 2015-06-30 | historic |
| Selling expenses | 181,876,012 | 0.00709 | 495 | 2015-06-30 | historic |
| Comprehensive income attributable to minority shareholders | 2,360,490 | 9.0E-5 | 505 | 2015-06-30 | historic |
| Goodwill | 31,492,082 | 0.00123 | 506 | 2015-06-30 | historic |
| Minority interests gain | 2,360,490 | 9.0E-5 | 515 | 2015-06-30 | historic |
| Net change in cash | 37,474,617 | 0.00146 | 604 | 2015-06-30 | historic |
| Cash paid for taxes | 214,907,357 | 0.00838 | 611 | 2015-06-30 | historic |
| Other current assets | 100,000,000 | 0.0039 | 644 | 2015-06-30 | historic |
| Other receivables | 112,175,394 | 0.00437 | 646 | 2015-06-30 | historic |
| Operating profit | 204,387,707 | 0.00797 | 676 | 2015-06-30 | historic |
| Short term borrowings | 751,600,000 | 0.02929 | 685 | 2015-06-30 | historic |
| Net income | 182,065,911 | 0.0071 | 709 | 2015-06-30 | historic |
| Total comprehensive income | 182,065,911 | 0.0071 | 713 | 2015-06-30 | historic |
| Total profit | 216,996,158 | 0.00846 | 720 | 2015-06-30 | historic |
| Cash paid for dividends, profits or interests | 112,631,337 | 0.00439 | 779 | 2015-06-30 | historic |
| Financial expenses | 10,812,584 | 4.2E-4 | 844 | 2015-06-30 | historic |
| Inventories | 762,108,029 | 0.0297 | 891 | 2015-06-30 | historic |
| Minority interest | 28,473,522 | 0.00111 | 907 | 2015-06-30 | historic |
| Net cashflow from financing activities | -108,104,537 | -0.00421 | 910 | 2015-06-30 | historic |
| Prepayment | 79,850,209 | 0.00311 | 961 | 2015-06-30 | historic |
| Intangible assets | 184,605,491 | 0.00719 | 973 | 2015-06-30 | historic |
| Net cash and cash equivalents ending balance | 699,259,411 | 0.02725 | 984 | 2015-06-30 | historic |
| Purchases of fixed assets and others | 60,553,961 | 0.00236 | 995 | 2015-06-30 | historic |
| Other payables | 61,193,590 | 0.00238 | 1004 | 2015-06-30 | historic |
| Cash inflows from financing activities | 289,026,800 | 0.01126 | 1006 | 2015-06-30 | historic |
| Capital reserve | 1,078,676,156 | 0.04204 | 1021 | 2015-06-30 | historic |
| Diluted eps | 0 | 0.0 | 1068 | 2015-06-30 | historic |
| Fixed assets | 562,039,739 | 0.0219 | 1071 | 2015-06-30 | historic |
| Non-operating loss | 235,290 | 1.0E-5 | 1146 | 2015-06-30 | historic |
| Cash inflows from operating activities | 908,058,011 | 0.03539 | 1150 | 2015-06-30 | historic |
| Total liabilities | 1,093,759,234 | 0.04262 | 1153 | 2015-06-30 | historic |
| Deferred tax assets | 9,131,427 | 3.6E-4 | 1162 | 2015-06-30 | historic |
| Revenue | 813,548,698 | 0.0317 | 1171 | 2015-06-30 | historic |
| Accounts payable | 148,296,827 | 0.00578 | 1180 | 2015-06-30 | historic |
| Total cost of goods sold | 610,360,435 | 0.02379 | 1193 | 2015-06-30 | historic |
| Payroll payable | 7,180,908 | 2.8E-4 | 1222 | 2015-06-30 | historic |
| Cash outflows from operating activities | 704,604,340 | 0.02746 | 1228 | 2015-06-30 | historic |
| Total non-current assets | 915,414,849 | 0.03567 | 1246 | 2015-06-30 | historic |
| Total liabilities and equity | 3,529,652,432 | 0.13755 | 1268 | 2015-06-30 | historic |